Solvay third quarter 2026 results

Summary by AI BETAClose X

Solvay reported Q3 2026 underlying net sales of €1,031m, down -3.3% organically, and underlying EBITDA of €173m (16.8% margin), down -26.6% organically with a ~€25m negative impact from the Middle East conflict; underlying net profit from continuing operations was €35m (Q3 2025: €90m). Free cash flow for the first nine months was €70m (Q3: €54m), 9M capex €203m, and underlying net debt €1.8bn (leverage 2.4x). The Board approved an interim dividend of €0.97 gross per share. 2026 guidance is maintained at underlying EBITDA €720–740m and Free Cash Flow €120–150m; rare‑earths JV talks with OneIM continue and a Viridis feedstock deal starts in 2028.

Disclaimer*

Companies

Solvay SA (0NZR)
UK 100

Latest directors dealings